Micropapillary Serous Ovarian Carcinoma: Surgical Management and Clinical Outcome
β Scribed by Robert E. Bristow; Dana R. Gossett; David R. Shook; Mariana L. Zahurak; Rafael S. Tomacruz; Deborah K. Armstrong; F.J. Montz
- Book ID
- 112251890
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 162 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Ovarian serous borderline tumors recently were categorized into benign and malignant types. A subset of these tumors, termed βmicropapillary serous carcinoma (MPSC),β is reported to behave in a manner similar to lowβgrade carcinoma. In this issue of __Cancer__, Bristow et al. report their experience
## Background: The objectives of the current study were to: 1) characterize the clinical outcome of patients with recurrent micropapillary serous ovarian carcinoma (mpsc) and 2) evaluate the survival impact of secondary cytoreductive surgery and other prognostic variables. ## Methods: Twenty-six